Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Carcinoma, Non-Small-Cell Lung 20Nasopharyngeal Carcinoma 8Lung Neoplasms 7Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Melanoma 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Sarcoma 2Osteosarcoma 2Nasopharyngeal Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Radiation Injuries 1Quality of Life 1Pleural Effusion, Malignant 1Non-squamous Non-small Cell Lung Cancer 1Neuroblastoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bone Neoplasms 1Advanced Pancreatic Cancer 1

Interventions

Cyclophosphamide 32Etoposide 18romidepsin 17fludarabine 17Vincristine 17Doxorubicin 16Rituximab 14Prednisone 14Melphalan 14Gemcitabine 13Brentuximab Vedotin 13Lenalidomide 12Peripheral Blood Stem Cell Transplantation 11Cytarabine 11Whole-Body Irradiation 10Biopsy 1010-propargyl-10-deazaaminopterin 10pembrolizumab 9fludarabine phosphate 9Specimen Handling 9Busulfan 9Mycophenolic Acid 8Granulocyte Colony-Stimulating Factor 8Depsipeptides 8Carmustine 8Bortezomib 8duvelisib 7Vorinostat 7Methotrexate 7Magnetic Resonance Spectroscopy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × endostar protein × Clear all
NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, T-Cell

NCT00974324 2010-09-15

PTCL

Fudan University

Phase 2 Unknown
15 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡